Shigeyoshi Saito Selected Research

N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)

5/2011

Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeyoshi Saito Research Topics

Disease

8	Neoplasms (Cancer) 04/2022 - 01/2011
3	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 10/2010
3	Fibrosis (Cirrhosis) 01/2022 - 01/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 06/2019 - 01/2019
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Ischemia 01/2021 - 01/2020
2	Brain Neoplasms (Brain Tumor) 10/2019 - 10/2010
2	Body Weight (Weight, Body) 07/2013 - 01/2012
2	Mesothelioma 05/2011 - 01/2011
1	Hepatic Encephalopathy 04/2022
1	Hypertrophy 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Fatty Liver 01/2022
1	Inflammation (Inflammations) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021
1	Stroke (Strokes) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2020
1	Leukemia 04/2020
1	Neuroblastoma 10/2019
1	Breast Neoplasms (Breast Cancer) 10/2019
1	Hemorrhage 10/2019
1	Disease Progression 01/2019
1	Leigh Disease (Leigh's Disease) 01/2019
1	Myocardial Infarction 01/2019
1	Pelizaeus-Merzbacher Disease 02/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2012
1	Malignant Mesothelioma 05/2011
1	Adenocarcinoma of Lung 05/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2011
1	Gliosarcoma 10/2010

Drug/Important Bio-Agent (IBA)

3	Protons (Proton)IBA 04/2022 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 06/2019 - 01/2019
3	ManganeseIBA 01/2012 - 01/2011
2	APTIBA 04/2022 - 10/2019
2	AmidesIBA 04/2022 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 03/2019 - 01/2019
2	Contrast MediaIBA 07/2013 - 05/2011
2	Superoxide DismutaseIBA 05/2011 - 01/2011
1	Thioacetamide (Thioacetamid)IBA 04/2022
1	Temozolomide (Temodar)FDA LinkGeneric 04/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2022
1	CalciumIBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022
1	CholesterolIBA 01/2022
1	InflammasomesIBA 01/2022
1	Sesame Oil (Oil, Sesame)IBA 01/2022
1	Alprostadil (Muse)FDA LinkGeneric 01/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	MonocrotalineIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Semaxinib (SU5416)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	CreatineIBA 01/2021
1	Therapeutic UsesIBA 04/2020
1	AntigensIBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2019
1	Hematoxylin (Haematoxylon)IBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 08/2013
1	Epidermal Growth Factor (EGF)IBA 08/2013
1	Ferrosoferric Oxide (Magnetite)FDA Link 08/2013
1	gadolinium ethoxybenzyl DTPA FDA Link 07/2013
1	Cyclin D1IBA 06/2013
1	N-acetylaspartate (N-acetyl aspartate)IBA 02/2012
1	isospaglumic acid (NAAGA)IBA 02/2012
1	antineoplaston A10 (A 10)IBA 01/2012
1	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 05/2011
1	manganese chloride (manganese chloride, tetrahydrate)FDA Link 05/2011
1	AsbestosIBA 05/2011
1	Iron-Binding ProteinsIBA 02/2011
1	Ferritins (Ferritin)IBA 02/2011
1	Neomycin FDA LinkGeneric 01/2011
1	Biological FactorsIBA 01/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2010
1	InterferonsIBA 10/2010
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2010
1	Peptide Hydrolases (Proteases)FDA Link 10/2010

Therapy/Procedure

2	Radiotherapy 06/2013 - 01/2012
1	Drug Therapy (Chemotherapy) 04/2022
1	Heart Transplantation (Grafting, Heart) 01/2022
1	Synchrotrons 01/2021
1	Tourniquets 01/2020
1	Therapeutics 01/2016